Holly Hagan
Holly Hagan
Professor Emeritus
-
Professional overview
-
Dr. Holly Hagan is Professor Emeritus at the School of Global Public Health. Trained as an infectious disease epidemiologist, Dr. Hagan’s work has sought to understand the causes and consequences of substance use disorders. Her research has examined blood-borne and sexually-transmitted infections among people who use drugs. She is an internationally-recognized expert in the etiology, epidemiology, natural history, prevention and treatment of hepatitis C virus infection among PWUD, and in 2014 her work was recognized by the US Department of Health and Human Services with the President’s Award for Leadership in the Control of Viral Hepatitis in the United States. Dr. Hagan served on the Institute of Medicine Committee on the Prevention and Control of Viral Hepatitis in the United States, and she has been an advisor to the US Department of Health and Human Services, the CDC, and the Canadian Institutes of Health on national programs to detect, diagnose and treat HCV infections. She was recently appointed to the National Academy of Medicine Committee on the Examination of the Integration of Opioid and Infectious Disease Prevention Efforts in Select Programs.
Dr. Hagan is the Director of the NIDA P30 Center for Drug Use and HIV|HCV Research at Global Public Health, which provides research support to investigators throughout NYU and in two other NYC institutions. In 2017, she was selected by NIDA to chair the Executive Steering Committee for the Rural Opioid Initiative funded by NIH, CDC, SAMHSA and the Appalachian Regional Commission. Her research has shifted to examining the impact of the opioid crisis more broadly, to include studying the epidemiology of fatal and non-fatal overdose among PWUD. She was chosen by the American Foundation for AIDS Research to be the Principal Investigator for the New York State Opioid Prevention Center pilot study, which will examine the safety and effectiveness of the Supervised Consumption Sites to be implemented in New York City and in upstate NY.
-
Education
-
PhD Epidemiology, University of Washington, Seattle, WAMPH Epidemiology, University of Massachusetts, Amherst, MABA Russian Studies, Evergreen State College, Olympia, WA
-
Publications
Publications
Preventing Epidemics of HIV-1 among Injecting Drug Users
Failed retrieving data.Regional Patterns and Correlates of Substance Use among Young Men Who Have Sex with Men in 7 US Urban Areas
Failed retrieving data.The relevance of attributable risk measures to HIV prevention planning
Failed retrieving data.The Tacoma syringe exchange studies : Public health practice influences research
Failed retrieving data.Case-reporting of acute hepatitis B and C among injection drug users
Failed retrieving data.Hepatitis B vaccination among research participants, Seattle, Washington
Failed retrieving data.Impact of the September 11th attacks in New York City on drug users : A preliminary assessment
Failed retrieving data.Supervised injection rooms - Prospects and limitations
Failed retrieving data.Syphilis among intravenous drug-using population : Epidemiological situation in St Petersburg, Russia
Failed retrieving data.Hepatitis B virus genotypes and HBsAg subtypes in refugees and injection drug users in the United States determined by LiPA and monoclonal EIA
Failed retrieving data.Predictors of accidental fatal drug overdose among a cohort of injection drug users
Failed retrieving data.Public health and changes in illicit drug prices
Failed retrieving data.Sharing of drug preparation equipment as a risk factor for hepatitis C
Failed retrieving data.Using a jail-based survey to monitor HIV and risk behaviors among Seattle area injection drug users
Failed retrieving data.Changes in injection risk behavior associated with participation in the Seattle needle-exchange program
Failed retrieving data.HIV and HCV infection among injecting drug users
Failed retrieving data.Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area
Failed retrieving data.Re : 'Syringe exchange and risk of infection with hepatitis B and C viruses' [2] (multiple letters)
Failed retrieving data.Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors
Failed retrieving data.Vaccination could improve overall health in a high risk population.
Failed retrieving data.Volunteer bias in nonrandomized evaluations of the efficacy of needle- exchange programs
Failed retrieving data.Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users : A quasi-randomised trial
Failed retrieving data.Invited commentary : Needle exchange - No help for hepatitis?
Failed retrieving data.Syringe exchange and risk of infection with hepatitis B and C viruses
Failed retrieving data.Hepatitis C virus transmission dynamics in injection drug users
Failed retrieving data.